期刊文献+

原发性中枢神经系统淋巴瘤的诊断和治疗 被引量:1

Diagnosis and treatment for primary central nervous system lymphoma
下载PDF
导出
摘要 目的:探讨原发性中枢神经系统淋巴瘤的诊断及治疗方法。方法:回顾性分析经手术病理证实的23例原发性中枢神经系统淋巴瘤的临床资料。结果:术后2年内复发8例。手术联合放疗化疗者平均生存45个月,单纯放疗或手术者平均生存18个月。结论:原发性中枢神经系统淋巴瘤患者预后差,综合治疗有利于改善患者预后。 Objective: To investigate the diagnosis and treatment of primary central nervous system lymphoma. Methods: The clinical data of 23 patients with primary central nervous system lymphoma proved by operation and pathology were analyzed retrospectively. Results: 20 of 23 patients were performed by surgical treament. Recurrence happened in 8 cases two years later. Patients who were given surgery, chemotherapy combined with radiotherapy had the average survival of 45 months.The others had the average survival of 18 months. Conclusion: Patients with primary central nervous system lymphoma often have poor prognosis. Comprehensive treatment will help improve the prognosis of patients.
出处 《天津医科大学学报》 2009年第2期263-265,284,共4页 Journal of Tianjin Medical University
关键词 中枢神经系统 淋巴瘤 诊断 治疗 Central nervous system Lymphoma Diagnosis Treament
  • 相关文献

参考文献13

二级参考文献46

共引文献56

同被引文献11

  • 1Gavrilovic I T, Abrey L E. Primary central nervous system lymphoma[J]. CurrOncolRep, 2004, 6(5):388-391.
  • 2Schlegel U, Jurgens A, Pels H. Primary central nervous system lymphoma (PCNSL) : MRI response criteria revised[J]. Neurology, 2006, 66(8) :1287.
  • 3Costa H, Franco M, Hahn M D. Primary lymphoma of the cen tral nervous system: a clinical-pathological and immunohisto chemical study of ten autopsy cases[J]. Arq Neuropsiquiatr 2006, 64(4) :976-982.
  • 4Lister A, Abrey L E, Sandlund J T. Central nervous system lymphoma[J]. Hematology, 2002, 7(1): 283-296.
  • 5Yamanaka R. Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment[J]. Brain Nerve, 2009, 61(10) :1155-1164.
  • 6Reni M, Zaja F, Mason W, et al. Temozolomide as salvage treatment in recurrent primary brain lymphomas[J]. Br J Cancer, 2007,96(6) 864-867.
  • 7Kurzwelly D, Glas M, Roth P, et al. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status [J]. J Neurooncol,2010, 97(3) 389- 392.
  • 8Omuro A M, Taillandier L, Chinot O, et al. Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly[J]. J Neurooncol, 2007, 85(2): 207-211.
  • 9Wong E T, Tishler R, Barron L, et al. Immunochemotherapy with rituximah and temozolomide for central nervous system lymphomas[J]. Cancer, 2004, 101(1): 139-145.
  • 10Santisteban M, Nieto Y, De la Cruz S, et al. Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line sehedule[J].Clin Transl Oncol, 2007,9 (7) :465-467.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部